Targeting PKM2 improves the gemcitabine sensitivity of intrahepatic cholangiocarcinoma cells via inhibiting β-catenin signaling pathway

Autor: Yu, Wenna a, 1, Zeng, Fuling b, 1, Xiao, Yang b, 1, Chen, Liuyan b, Qu, Hengdong b, Hong, Jian b, c, Qu, Chen b, ∗∗, Cheng, Guohua a, ∗
Zdroj: In Chemico-Biological Interactions 5 January 2024 387
Databáze: ScienceDirect